| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | MHC class Ib protein binding | 2.00e-06 | 16 | 118 | 4 | GO:0023029 | |
| GeneOntologyMolecularFunction | MHC class Ib receptor activity | 4.19e-06 | 19 | 118 | 4 | GO:0032394 | |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 1.54e-04 | 18 | 118 | 3 | GO:0032393 | |
| GeneOntologyMolecularFunction | MHC protein binding | 3.84e-04 | 58 | 118 | 4 | GO:0042287 | |
| GeneOntologyMolecularFunction | immune receptor activity | 4.47e-04 | 165 | 118 | 6 | GO:0140375 | |
| GeneOntologyMolecularFunction | single-stranded DNA 3'-5' DNA exonuclease activity | 5.11e-04 | 6 | 118 | 2 | GO:0008310 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 5.11e-04 | 6 | 118 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 9.47e-04 | 8 | 118 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SHANK1 NPM1 DLGAP2 ANK3 KAT6A LRRK2 OBSL1 TRIM21 SKI SFMBT2 LIAT1 ZAR1 KIR3DL3 PHF14 KIR2DL1 KIR2DL3 KIR3DL1 TP53BP1 | 9.99e-04 | 1356 | 118 | 18 | GO:0060090 |
| Domain | RIBOSOMAL_S4E | 2.33e-07 | 3 | 116 | 3 | PS00528 | |
| Domain | Ribosomal_S4e_central_region | 2.33e-07 | 3 | 116 | 3 | IPR013845 | |
| Domain | Ribosomal_S4e_N | 2.33e-07 | 3 | 116 | 3 | IPR013843 | |
| Domain | Ribosomal_S4e_central | 2.33e-07 | 3 | 116 | 3 | PD002667 | |
| Domain | 40S_S4_C | 2.33e-07 | 3 | 116 | 3 | PF16121 | |
| Domain | 40S_S4_C | 2.33e-07 | 3 | 116 | 3 | IPR032277 | |
| Domain | Ribosomal_S4e_N_CS | 2.33e-07 | 3 | 116 | 3 | IPR018199 | |
| Domain | RS4NT | 2.33e-07 | 3 | 116 | 3 | PF08071 | |
| Domain | Ribosomal_S4e | 2.33e-07 | 3 | 116 | 3 | IPR000876 | |
| Domain | Ribosomal_S4e | 2.33e-07 | 3 | 116 | 3 | PF00900 | |
| Domain | ZF_PHD_1 | 2.24e-06 | 96 | 116 | 7 | PS01359 | |
| Domain | S4 | 2.31e-06 | 5 | 116 | 3 | SM00363 | |
| Domain | S4 | 2.31e-06 | 5 | 116 | 3 | PS50889 | |
| Domain | ig | DSCAM OBSL1 KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS5 KIR3DL1 KIR3DS1 | 2.89e-06 | 190 | 116 | 9 | PF00047 |
| Domain | Immunoglobulin | DSCAM OBSL1 KIR2DS2 KIR3DL3 KIR2DL1 KIR2DL3 KIR2DS5 KIR3DL1 KIR3DS1 | 2.89e-06 | 190 | 116 | 9 | IPR013151 |
| Domain | Zinc_finger_PHD-type_CS | 3.09e-06 | 65 | 116 | 6 | IPR019786 | |
| Domain | S4_RNA-bd | 4.61e-06 | 6 | 116 | 3 | IPR002942 | |
| Domain | PHD | 7.16e-06 | 75 | 116 | 6 | PF00628 | |
| Domain | Znf_PHD-finger | 9.68e-06 | 79 | 116 | 6 | IPR019787 | |
| Domain | PHD | 1.92e-05 | 89 | 116 | 6 | SM00249 | |
| Domain | Znf_PHD | 2.19e-05 | 91 | 116 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.79e-05 | 95 | 116 | 6 | PS50016 | |
| Domain | Znf_FYVE_PHD | 3.70e-05 | 147 | 116 | 7 | IPR011011 | |
| Domain | KOW | 3.71e-05 | 11 | 116 | 3 | IPR005824 | |
| Domain | KOW | 3.71e-05 | 11 | 116 | 3 | PF00467 | |
| Domain | NPIP | 8.08e-05 | 14 | 116 | 3 | IPR009443 | |
| Domain | Tscrpt_reg_SKI_SnoN | 2.28e-04 | 4 | 116 | 2 | IPR023216 | |
| Domain | Lys_sp_deMease-like_dom | 2.28e-04 | 4 | 116 | 2 | IPR013637 | |
| Domain | c-SKI_SMAD_bind | 2.28e-04 | 4 | 116 | 2 | PF08782 | |
| Domain | FAM47 | 2.28e-04 | 4 | 116 | 2 | PF14642 | |
| Domain | S4 | 2.28e-04 | 4 | 116 | 2 | PF01479 | |
| Domain | c-SKI_SMAD_bind | 2.28e-04 | 4 | 116 | 2 | SM01046 | |
| Domain | c-SKI_SMAD4-bd_dom | 2.28e-04 | 4 | 116 | 2 | IPR014890 | |
| Domain | PLU-1 | 2.28e-04 | 4 | 116 | 2 | PF08429 | |
| Domain | FAM47 | 2.28e-04 | 4 | 116 | 2 | IPR032743 | |
| Domain | IG | DSCAM OBSL1 KIR2DS2 KIR3DL3 KIR2DL1 MYBPHL KIR2DL3 KIR2DS5 KIR3DL1 KIR3DS1 | 2.96e-04 | 421 | 116 | 10 | SM00409 |
| Domain | Ig_sub | DSCAM OBSL1 KIR2DS2 KIR3DL3 KIR2DL1 MYBPHL KIR2DL3 KIR2DS5 KIR3DL1 KIR3DS1 | 2.96e-04 | 421 | 116 | 10 | IPR003599 |
| Domain | zf-C5HC2 | 3.78e-04 | 5 | 116 | 2 | PF02928 | |
| Domain | Znf_C5HC2 | 3.78e-04 | 5 | 116 | 2 | IPR004198 | |
| Domain | - | KDM5C KAT6A TRIM21 KDM5D RNF43 PHF21A TRIM45 TRIM66 PHF20L1 PHF14 | 4.91e-04 | 449 | 116 | 10 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | KDM5C KAT6A TRIM21 KDM5D RNF43 PHF21A TRIM45 TRIM66 PHF20L1 PHF14 | 5.83e-04 | 459 | 116 | 10 | IPR013083 |
| Domain | Ski_Sno | 7.87e-04 | 7 | 116 | 2 | PF02437 | |
| Domain | - | 7.87e-04 | 7 | 116 | 2 | 3.10.260.20 | |
| Domain | Transform_Ski | 7.87e-04 | 7 | 116 | 2 | IPR003380 | |
| Domain | BBOX | 8.95e-04 | 69 | 116 | 4 | SM00336 | |
| Domain | - | 9.96e-04 | 71 | 116 | 4 | 4.10.45.10 | |
| Domain | zf-B_box | 1.05e-03 | 72 | 116 | 4 | PF00643 | |
| Domain | ZU5 | 1.34e-03 | 9 | 116 | 2 | SM00218 | |
| Domain | ZF_BBOX | 1.55e-03 | 80 | 116 | 4 | PS50119 | |
| Domain | Znf_B-box | 1.63e-03 | 81 | 116 | 4 | IPR000315 | |
| Domain | MBT | 1.67e-03 | 10 | 116 | 2 | PF02820 | |
| Domain | JmjN | 1.67e-03 | 10 | 116 | 2 | SM00545 | |
| Domain | Mbt | 1.67e-03 | 10 | 116 | 2 | IPR004092 | |
| Domain | JmjN | 1.67e-03 | 10 | 116 | 2 | PF02375 | |
| Domain | JMJN | 1.67e-03 | 10 | 116 | 2 | PS51183 | |
| Domain | ZU5 | 1.67e-03 | 10 | 116 | 2 | PS51145 | |
| Domain | Ank_3 | 1.67e-03 | 10 | 116 | 2 | PF13606 | |
| Domain | JmjN | 1.67e-03 | 10 | 116 | 2 | IPR003349 | |
| Domain | SH3_2 | 2.03e-03 | 86 | 116 | 4 | PF07653 | |
| Domain | SH3_2 | 2.03e-03 | 86 | 116 | 4 | IPR011511 | |
| Domain | DNA-bd_dom_put | 2.03e-03 | 11 | 116 | 2 | IPR009061 | |
| Domain | - | 2.42e-03 | 12 | 116 | 2 | 3.10.390.10 | |
| Domain | ZU5 | 2.42e-03 | 12 | 116 | 2 | PF00791 | |
| Domain | ZU5_dom | 2.42e-03 | 12 | 116 | 2 | IPR000906 | |
| Domain | SAND_dom-like | 2.42e-03 | 12 | 116 | 2 | IPR010919 | |
| Domain | IG_LIKE | DSCAM OBSL1 KIR2DS2 KIR3DL3 KIR2DL1 MYBPHL KIR2DL3 KIR2DS5 KIR3DL1 | 3.55e-03 | 491 | 116 | 9 | PS50835 |
| Domain | Bbox_C | 3.81e-03 | 15 | 116 | 2 | IPR003649 | |
| Domain | - | 3.81e-03 | 15 | 116 | 2 | 1.10.150.60 | |
| Domain | BBC | 3.81e-03 | 15 | 116 | 2 | SM00502 | |
| Domain | BRIGHT | 3.81e-03 | 15 | 116 | 2 | SM00501 | |
| Domain | ARID_dom | 3.81e-03 | 15 | 116 | 2 | IPR001606 | |
| Domain | ARID | 3.81e-03 | 15 | 116 | 2 | PS51011 | |
| Domain | ARID | 3.81e-03 | 15 | 116 | 2 | PF01388 | |
| Domain | Ig-like_dom | DSCAM OBSL1 KIR2DS2 KIR2DL1 MYBPHL KIR2DL3 KIR2DS5 KIR3DL1 KIR3DS1 | 4.15e-03 | 503 | 116 | 9 | IPR007110 |
| Domain | Ig-like_fold | DSCAM OBSL1 KIR2DS2 TRIM45 KIR3DL3 KIR2DL1 MYBPHL KIR2DL3 KIR2DS5 KIR3DL1 KIR3DS1 | 4.49e-03 | 706 | 116 | 11 | IPR013783 |
| Domain | - | 4.54e-03 | 248 | 116 | 6 | 1.25.40.20 | |
| Domain | ANK_REPEAT | 5.00e-03 | 253 | 116 | 6 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 5.10e-03 | 254 | 116 | 6 | IPR020683 | |
| Domain | ANK_REP_REGION | 5.10e-03 | 254 | 116 | 6 | PS50297 | |
| Domain | Ankyrin_rpt | 5.91e-03 | 262 | 116 | 6 | IPR002110 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptor gene and its correlation with leukemia]. | 4.81e-15 | 12 | 124 | 7 | 17490516 | |
| Pubmed | 2.07e-14 | 14 | 124 | 7 | 19875891 | ||
| Pubmed | Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. | 2.07e-14 | 14 | 124 | 7 | 15896204 | |
| Pubmed | 3.88e-14 | 15 | 124 | 7 | 20082646 | ||
| Pubmed | 3.88e-14 | 15 | 124 | 7 | 20356536 | ||
| Pubmed | 3.88e-14 | 15 | 124 | 7 | 19926642 | ||
| Pubmed | 3.88e-14 | 15 | 124 | 7 | 20643584 | ||
| Pubmed | 3.88e-14 | 15 | 124 | 7 | 19326408 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 19897003 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 19000141 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 20670355 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 18668235 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 19309280 | ||
| Pubmed | Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage. | 6.87e-14 | 16 | 124 | 7 | 19527230 | |
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 20652381 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 19279038 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 17868255 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 18643961 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 20331834 | ||
| Pubmed | 6.87e-14 | 16 | 124 | 7 | 20210919 | ||
| Pubmed | 1.16e-13 | 17 | 124 | 7 | 19968064 | ||
| Pubmed | Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection. | 1.16e-13 | 17 | 124 | 7 | 20878400 | |
| Pubmed | 1.16e-13 | 17 | 124 | 7 | 20650299 | ||
| Pubmed | 1.16e-13 | 17 | 124 | 7 | 20173792 | ||
| Pubmed | 1.16e-13 | 17 | 124 | 7 | 20483367 | ||
| Pubmed | [Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese]. | 1.16e-13 | 17 | 124 | 7 | 19218127 | |
| Pubmed | 1.16e-13 | 17 | 124 | 7 | 19169284 | ||
| Pubmed | 1.16e-13 | 17 | 124 | 7 | 19450876 | ||
| Pubmed | 1.16e-13 | 17 | 124 | 7 | 19761533 | ||
| Pubmed | Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis. | 1.90e-13 | 18 | 124 | 7 | 19630074 | |
| Pubmed | Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians. | 1.90e-13 | 18 | 124 | 7 | 19046302 | |
| Pubmed | 1.90e-13 | 18 | 124 | 7 | 20580654 | ||
| Pubmed | 1.90e-13 | 18 | 124 | 7 | 20519398 | ||
| Pubmed | 1.90e-13 | 18 | 124 | 7 | 19846535 | ||
| Pubmed | 1.90e-13 | 18 | 124 | 7 | 20210918 | ||
| Pubmed | KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. | 3.00e-13 | 19 | 124 | 7 | 18571006 | |
| Pubmed | Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil. | 3.00e-13 | 19 | 124 | 7 | 18778326 | |
| Pubmed | 3.00e-13 | 19 | 124 | 7 | 20600442 | ||
| Pubmed | 3.00e-13 | 19 | 124 | 7 | 18848853 | ||
| Pubmed | Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay. | 4.60e-13 | 20 | 124 | 7 | 20193031 | |
| Pubmed | 6.88e-13 | 21 | 124 | 7 | 19861144 | ||
| Pubmed | 8.28e-13 | 11 | 124 | 6 | 18830515 | ||
| Pubmed | [Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients]. | 8.28e-13 | 11 | 124 | 6 | 19664392 | |
| Pubmed | 1.01e-12 | 22 | 124 | 7 | 20492596 | ||
| Pubmed | 1.65e-12 | 12 | 124 | 6 | 20371502 | ||
| Pubmed | 1.65e-12 | 12 | 124 | 6 | 19936734 | ||
| Pubmed | Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome. | 1.65e-12 | 12 | 124 | 6 | 19181658 | |
| Pubmed | 1.65e-12 | 12 | 124 | 6 | 20137308 | ||
| Pubmed | 3.06e-12 | 13 | 124 | 6 | 19934297 | ||
| Pubmed | 3.06e-12 | 13 | 124 | 6 | 19120281 | ||
| Pubmed | 3.06e-12 | 13 | 124 | 6 | 18687225 | ||
| Pubmed | 5.33e-12 | 14 | 124 | 6 | 19489269 | ||
| Pubmed | Multiple sclerosis associates with LILRA3 deletion in Spanish patients. | 5.33e-12 | 14 | 124 | 6 | 19421224 | |
| Pubmed | 5.33e-12 | 14 | 124 | 6 | 18945962 | ||
| Pubmed | 8.86e-12 | 15 | 124 | 6 | 19850842 | ||
| Pubmed | Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma. | 8.86e-12 | 15 | 124 | 6 | 20207982 | |
| Pubmed | 8.86e-12 | 15 | 124 | 6 | 19493232 | ||
| Pubmed | KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. | 8.86e-12 | 15 | 124 | 6 | 17498266 | |
| Pubmed | Immunogenetic characteristics of patients with autoimmune gastritis. | 9.02e-12 | 29 | 124 | 7 | 20082482 | |
| Pubmed | [Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population]. | 1.41e-11 | 16 | 124 | 6 | 16403292 | |
| Pubmed | 2.18e-11 | 17 | 124 | 6 | 19032228 | ||
| Pubmed | 2.18e-11 | 17 | 124 | 6 | 20173784 | ||
| Pubmed | 3.26e-11 | 18 | 124 | 6 | 20200544 | ||
| Pubmed | 3.82e-11 | 35 | 124 | 7 | 19683555 | ||
| Pubmed | 6.62e-11 | 9 | 124 | 5 | 7749980 | ||
| Pubmed | Alternatively spliced forms of human killer inhibitory receptors. | 6.62e-11 | 9 | 124 | 5 | 8662091 | |
| Pubmed | 6.76e-11 | 20 | 124 | 6 | 20426625 | ||
| Pubmed | 1.32e-10 | 10 | 124 | 5 | 12559621 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 7716543 | ||
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 12618911 | ||
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 14607943 | ||
| Pubmed | Expression of a killer cell receptor-like gene in plastic regions of the central nervous system. | 5.34e-09 | 7 | 124 | 4 | 15748957 | |
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 9430220 | ||
| Pubmed | KIR haplotype content at the allele level in 77 Northern Irish families. | 1.07e-08 | 8 | 124 | 4 | 17200871 | |
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 15730517 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 9430221 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 18681957 | ||
| Pubmed | 1.91e-08 | 9 | 124 | 4 | 18340360 | ||
| Pubmed | 3.18e-08 | 10 | 124 | 4 | 21206914 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 30698860 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 2124517 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 8187552 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 8808278 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 1783379 | ||
| Pubmed | 1.07e-07 | 13 | 124 | 4 | 14660691 | ||
| Pubmed | Structure and function of ribosomal protein S4 genes on the human and mouse sex chromosomes. | 1.76e-07 | 4 | 124 | 3 | 8139551 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 18632158 | ||
| Pubmed | Activating KIR genes are associated with ankylosing spondylitis in Asian populations. | 1.76e-07 | 4 | 124 | 3 | 18638658 | |
| Pubmed | Polymorphism and domain variability of human killer cell inhibitory receptors. | 1.76e-07 | 4 | 124 | 3 | 9059894 | |
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 19522772 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 27732638 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 21233146 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 18269867 | ||
| Pubmed | 1.76e-07 | 4 | 124 | 3 | 23354323 | ||
| Pubmed | RPS4Y2 NPM1 CACNA1C C8orf88 RPS4X RPS4Y1 ACO2 NOL6 SKI SFMBT2 ADAMTS12 PHF20L1 TJP1 FAM161A NAV2 PHF14 PLCH1 PCK1 LCMT1 RPL18A | 1.95e-07 | 1442 | 124 | 20 | 35575683 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 9562962 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 18755860 | ||
| Pubmed | Diversity of the repertoire of p58 killer cell inhibitory receptors in a single individual. | 4.40e-07 | 5 | 124 | 3 | 10424431 | |
| Pubmed | KIR 2D (L1, L3, L4, S4) and KIR 3DL1 protein expression in non-small cell lung cancer. | 4.40e-07 | 5 | 124 | 3 | 27893413 | |
| Pubmed | Maintenance of X inactivation of the Rps4, Zfx, and Ube1 genes in a mouse in vitro system. | 4.40e-07 | 5 | 124 | 3 | 7681608 | |
| Interaction | KIR3DP1 interactions | 8.20e-07 | 4 | 120 | 3 | int:KIR3DP1 | |
| Interaction | KIR2DL2 interactions | 8.20e-07 | 13 | 120 | 4 | int:KIR2DL2 | |
| Interaction | TEX10 interactions | 1.01e-05 | 175 | 120 | 8 | int:TEX10 | |
| Interaction | USP15 interactions | DOCK4 NPM1 ANK3 RPS4X KAT6A LRRK2 TRIM21 RNF43 MSH6 TJP1 RORC FHL1 RPL18A | 2.28e-05 | 546 | 120 | 13 | int:USP15 |
| Interaction | YWHAQ interactions | MYC NPM1 TNK1 SH3BP2 LRRK2 OBSL1 TRIM21 RNF43 PABIR2 MEFV CEP89 TJP1 TESK2 SH3D19 NAV2 PLCH1 PCK1 MACIR DNMT1 | 3.30e-05 | 1118 | 120 | 19 | int:YWHAQ |
| Interaction | SPATA1 interactions | 3.32e-05 | 31 | 120 | 4 | int:SPATA1 | |
| Interaction | SQSTM1 interactions | MYC NPM1 CACNA1C CIP2A ACO2 CHDH KAT6A LRRK2 OBSL1 TNRC6B TRIM21 ACAD10 SKI RNF43 PHF21A ADAMTS12 TJP1 CORO7 PCK1 DNMT1 | 5.07e-05 | 1257 | 120 | 20 | int:SQSTM1 |
| Interaction | KIR3DL1 interactions | 5.64e-05 | 13 | 120 | 3 | int:KIR3DL1 | |
| Cytoband | 19q13.4 | 2.18e-09 | 79 | 124 | 7 | 19q13.4 | |
| Cytoband | 16p12.2 | 1.40e-04 | 37 | 124 | 3 | 16p12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | SHANK1 BICRA PLEKHG2 LENG9 ZNF599 LIG1 CEP89 KIR3DL3 KIR2DL1 KIR2DL3 KIR3DL1 | 4.04e-04 | 1192 | 124 | 11 | chr19q13 |
| GeneFamily | CD molecules|Killer cell immunoglobulin like receptors | 8.50e-13 | 18 | 81 | 7 | 620 | |
| GeneFamily | PHD finger proteins | 1.54e-07 | 90 | 81 | 7 | 88 | |
| GeneFamily | SKI transcriptional corepressors | 1.18e-04 | 4 | 81 | 2 | 748 | |
| GeneFamily | S ribosomal proteins | 4.69e-04 | 34 | 81 | 3 | 728 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 8.73e-04 | 95 | 81 | 4 | 59 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.55e-03 | 51 | 81 | 3 | 870 | |
| GeneFamily | AT-rich interaction domain containing | 2.00e-03 | 15 | 81 | 2 | 418 | |
| GeneFamily | Integrator complex | 2.00e-03 | 15 | 81 | 2 | 1366 | |
| GeneFamily | PDZ domain containing | 4.84e-03 | 152 | 81 | 4 | 1220 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 5.13e-03 | 24 | 81 | 2 | 485 | |
| Coexpression | KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE | 1.17e-07 | 49 | 124 | 6 | M40909 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_STELLATE_CELL_AGEING | 8.50e-06 | 9 | 124 | 3 | MM3821 | |
| Coexpression | BILANGES_SERUM_RESPONSE_TRANSLATION | 2.50e-05 | 36 | 124 | 4 | MM1308 | |
| Coexpression | TABULA_MURIS_SENIS_KIDNEY_FIBROBLAST_AGEING | 3.45e-05 | 39 | 124 | 4 | MM3721 | |
| Coexpression | TABULA_MURIS_SENIS_THYMUS_PROFESSIONAL_ANTIGEN_PRESENTING_CELL_AGEING | 4.20e-05 | 81 | 124 | 5 | MM3848 | |
| Coexpression | GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN | 4.80e-05 | 200 | 124 | 7 | M3513 | |
| Coexpression | GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN | 4.80e-05 | 200 | 124 | 7 | M6543 | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 7.54e-07 | 185 | 121 | 7 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 8.11e-07 | 187 | 121 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.00e-06 | 193 | 121 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-06 | 194 | 121 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | VE-CD4-memory_CD4|VE / Condition, Cell_class and T cell subcluster | 1.19e-06 | 198 | 121 | 7 | ef580576d6669ac7051e8f93fec2f2cd3887e64e | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.23e-06 | 199 | 121 | 7 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-CD4+_Tcm|Leuk-UTI / Disease, condition lineage and cell class | 1.23e-06 | 199 | 121 | 7 | 22a16381ad68e758aa8e44fa0d6d5a2335aa5fe3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 200 | 121 | 7 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 3.35e-06 | 149 | 121 | 6 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | severe_influenza-CD4+_T_naive|severe_influenza / disease group, cell group and cell class (v2) | 4.70e-06 | 158 | 121 | 6 | ff3fa4bd06e01363429aec4bb587b95819bf0fc9 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.42e-06 | 162 | 121 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.39e-06 | 171 | 121 | 6 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.59e-06 | 179 | 121 | 6 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.02e-05 | 181 | 121 | 6 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 183 | 121 | 6 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-05 | 185 | 121 | 6 | f60b39010b9210a5f18ccd113758512bd15d7eec | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.19e-05 | 186 | 121 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 186 | 121 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | droplet-Lung-3m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.27e-05 | 188 | 121 | 6 | 0ec2a1b0505501ba18f10a5fce68c306a6292419 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_TCM|Bac-SEP / Disease, Lineage and Cell Type | 1.31e-05 | 189 | 121 | 6 | 70f918dc208cd7ce8de9007729d8c5743c56c130 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TCM|Leuk-UTI / Disease, Lineage and Cell Type | 1.35e-05 | 190 | 121 | 6 | 5f8d606d2f465ddeae7451835f84b3f25a151d2a | |
| ToppCell | (1)_T_cells-(1)_T_CD8_gd|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.35e-05 | 190 | 121 | 6 | 268772d2adff34f7175b8474e95b67fd96dc1234 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-05 | 191 | 121 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.39e-05 | 191 | 121 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-05 | 191 | 121 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.43e-05 | 192 | 121 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.47e-05 | 193 | 121 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | severe-CD4+_Tcm|severe / disease stage, cell group and cell class | 1.51e-05 | 194 | 121 | 6 | 380fbd19b72af6767f98bbf50329686b76d59c54 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 194 | 121 | 6 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 194 | 121 | 6 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_conv|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.56e-05 | 195 | 121 | 6 | 67ea0d48a31feed886e356a71740981b64f4d658 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 1.56e-05 | 195 | 121 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.56e-05 | 195 | 121 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.56e-05 | 195 | 121 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 196 | 121 | 6 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.61e-05 | 196 | 121 | 6 | 64b23d819efddb25024c86f2e1b5dc4159337ddd | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.61e-05 | 196 | 121 | 6 | ba46f80d1497eaf4d71b59504106ba4b84e4ff9f | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.61e-05 | 196 | 121 | 6 | eb0b711ca6da7b5e5313791c3c3985358e2a222e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | 4edf043e8f586fd375f56485841fe992a18bf853 | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 1.65e-05 | 197 | 121 | 6 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | normal|World / PBMC cell types (v2) per disease, treatment status, and sex | 1.65e-05 | 197 | 121 | 6 | 232e48864aeb5ad6688352383427fb1771986ddc | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4|blood / Manually curated celltypes from each tissue | 1.70e-05 | 198 | 121 | 6 | a7e39a045e035beaf19f0f0aeb4248d0762da630 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Teffector/EM_CD4|blood / Manually curated celltypes from each tissue | 1.70e-05 | 198 | 121 | 6 | 1025036301e0bd7daa75bd8a86e123a70ad7adc7 | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 1.75e-05 | 199 | 121 | 6 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | ea1e3eeddbc398ac97863120f7aa3f17569ca12a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | 4a57f2f2dc6e2402ac4772b5cd38e033a6f1adee | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.80e-05 | 200 | 121 | 6 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.80e-05 | 200 | 121 | 6 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.80e-05 | 200 | 121 | 6 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD4+_Tcm|Bac-SEP / Disease, condition lineage and cell class | 1.80e-05 | 200 | 121 | 6 | fe0e0b25fbe2c7bad6bffef17f62bf346c83fc54 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 4.18e-05 | 141 | 121 | 5 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-05 | 144 | 121 | 5 | b638398f559e7fd9d4294d1c830beeb20f905960 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.93e-05 | 146 | 121 | 5 | 2d907e50206c4762a8baa741363bc7f0a04bd84e | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 5.26e-05 | 148 | 121 | 5 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 5.44e-05 | 149 | 121 | 5 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.96e-05 | 157 | 121 | 5 | 2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 7.18e-05 | 158 | 121 | 5 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 8.08e-05 | 162 | 121 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_Naive|ICU-SEP / Disease, Lineage and Cell Type | 8.31e-05 | 163 | 121 | 5 | 415e67aaae7ccd97a003b4b31b27eed94737deca | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.31e-05 | 163 | 121 | 5 | 466c8129852a5b16cd9fcc6b79e799abc21bb21a | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-05 | 164 | 121 | 5 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.56e-05 | 164 | 121 | 5 | 0853e75b60b2a78257b660910c3ee15b09c5f5b0 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_T_naive|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 9.32e-05 | 167 | 121 | 5 | 78d264af390bd89942ffbb2991dc94f50756d4c9 | |
| ToppCell | BAL-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 9.32e-05 | 167 | 121 | 5 | 6c5aa9077ae7eb8887269d405972bd5b31596b19 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-05 | 168 | 121 | 5 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like|GI_small-bowel / Manually curated celltypes from each tissue | 9.59e-05 | 168 | 121 | 5 | d02eba7ece17edcdd47fd6b784c93910ce61090f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.86e-05 | 169 | 121 | 5 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.01e-04 | 170 | 121 | 5 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.01e-04 | 170 | 121 | 5 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-ILC3|GI_small-bowel / Manually curated celltypes from each tissue | 1.01e-04 | 170 | 121 | 5 | 97df5ffb328196c46568975d2d97722bcc753bf5 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD4_Naive|Int-URO / Disease, Lineage and Cell Type | 1.01e-04 | 170 | 121 | 5 | 577915dd1f5c418b9b98a7a7153e2b5d1b93ca84 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 171 | 121 | 5 | 2a34685f7d83d1cf9a88d304173cbca868c5f9fd | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.07e-04 | 172 | 121 | 5 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 2b448acd5e584f24567204c31b8d74715e92f32a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-04 | 173 | 121 | 5 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 6c9ecf77d2fb0f89100fdd7e4e88f85598278bc7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | 5086edc29c5a6137ca09877929a1317f9739c801 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.13e-04 | 174 | 121 | 5 | d2ea5b55bf03a8013816d073896208f311c3e544 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.13e-04 | 174 | 121 | 5 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 175 | 121 | 5 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | severe_influenza-Plasmablast|World / disease group, cell group and cell class (v2) | 1.16e-04 | 175 | 121 | 5 | e6d6c44510d5dc4eb0bae820125e42366f7a4e74 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.19e-04 | 176 | 121 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-04 | 177 | 121 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-04 | 177 | 121 | 5 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 178 | 121 | 5 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | C_00|World / shred on cell type and cluster | 1.29e-04 | 179 | 121 | 5 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_TCM|URO / Disease, Lineage and Cell Type | 1.29e-04 | 179 | 121 | 5 | cdf972acf23c7a22c99a336ee0f9cc51e0fa6f67 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-04 | 179 | 121 | 5 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | BL-critical-LOC-Lymphoid-NKT|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.36e-04 | 181 | 121 | 5 | e3add2412c9f8eddfb77e0fbcd66fe57b23ae513 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 181 | 121 | 5 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 181 | 121 | 5 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.36e-04 | 181 | 121 | 5 | cc7ae1221a28bc404138a7efee0ad08a19cc3d86 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 182 | 121 | 5 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T8_naive-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.39e-04 | 182 | 121 | 5 | 3a3ed195c15d33d46a2f395cb93018e4bba28353 | |
| ToppCell | Mild-CD4+_T|World / Disease group and Cell class | 1.43e-04 | 183 | 121 | 5 | c4ac8893d38a3da4e19fe2ef1756bd69c89e975c | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.43e-04 | 183 | 121 | 5 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 184 | 121 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 1.47e-04 | 184 | 121 | 5 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| Disease | level of killer cell immunoglobulin-like receptor 2DS2 in blood serum | 5.47e-08 | 3 | 113 | 3 | OBA_2042107 | |
| Disease | ovarian neoplasm | 1.33e-05 | 134 | 113 | 6 | C0919267 | |
| Disease | ascending colon cancer (is_implicated_in) | 1.45e-05 | 2 | 113 | 2 | DOID:218 (is_implicated_in) | |
| Disease | Malignant neoplasm of ovary | 1.51e-05 | 137 | 113 | 6 | C1140680 | |
| Disease | killer cell immunoglobulin-like receptor 2DS2 measurement | 2.41e-05 | 15 | 113 | 3 | EFO_0801746 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 2.95e-05 | 16 | 113 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 8.68e-05 | 4 | 113 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Endometrial Carcinoma | 1.72e-04 | 72 | 113 | 4 | C0476089 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.05e-04 | 152 | 113 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | endometrial cancer (is_implicated_in) | 3.56e-04 | 36 | 113 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | ovarian cancer (implicated_via_orthology) | 4.01e-04 | 8 | 113 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 5.14e-04 | 9 | 113 | 2 | DOID:635 (is_implicated_in) | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 5.37e-04 | 97 | 113 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | mortality | 5.51e-04 | 173 | 113 | 5 | EFO_0004352 | |
| Disease | Childhood Medulloblastoma | 6.04e-04 | 43 | 113 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 6.04e-04 | 43 | 113 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 6.04e-04 | 43 | 113 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 6.04e-04 | 43 | 113 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 6.04e-04 | 43 | 113 | 3 | C0278876 | |
| Disease | theophylline measurement | 6.41e-04 | 10 | 113 | 2 | EFO_0021180 | |
| Disease | Anxiety States, Neurotic | 6.46e-04 | 44 | 113 | 3 | C0376280 | |
| Disease | Anxiety neurosis (finding) | 6.46e-04 | 44 | 113 | 3 | C1279420 | |
| Disease | Anxiety Disorders | 6.46e-04 | 44 | 113 | 3 | C0003469 | |
| Disease | nucleus accumbens volume change measurement | 7.82e-04 | 11 | 113 | 2 | EFO_0021493 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 9.36e-04 | 12 | 113 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | Medulloblastoma | 9.40e-04 | 50 | 113 | 3 | C0025149 | |
| Disease | triacylglycerol 48:4 measurement | 1.28e-03 | 14 | 113 | 2 | EFO_0010407 | |
| Disease | urate measurement, spine bone mineral density | 1.45e-03 | 58 | 113 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Endometrial Neoplasms | 1.45e-03 | 58 | 113 | 3 | C0014170 | |
| Disease | tuberculosis | 1.48e-03 | 216 | 113 | 5 | MONDO_0018076 | |
| Disease | creatinine measurement | CHAF1B DSCAM C3orf62 MAP3K14 TNRC6B ACAD10 INTS8 CEP89 MYBPHL PCK1 SOS2 | 1.54e-03 | 995 | 113 | 11 | EFO_0004518 |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 1.68e-03 | 16 | 113 | 2 | C1839071 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 1.68e-03 | 16 | 113 | 2 | cv:C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 1.68e-03 | 16 | 113 | 2 | 415000 | |
| Disease | childhood onset asthma | 1.84e-03 | 334 | 113 | 6 | MONDO_0005405 | |
| Disease | hypertrophic cardiomyopathy (is_marker_for) | 1.90e-03 | 17 | 113 | 2 | DOID:11984 (is_marker_for) | |
| Disease | age at menarche | 2.07e-03 | 594 | 113 | 8 | EFO_0004703 | |
| Disease | Malignant neoplasm of endometrium | 2.14e-03 | 18 | 113 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 2.14e-03 | 18 | 113 | 2 | C0346191 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.38e-03 | 145 | 113 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | Nonorganic psychosis | 2.38e-03 | 69 | 113 | 3 | C0349204 | |
| Disease | Colonic Neoplasms | 2.82e-03 | 152 | 113 | 4 | C0009375 | |
| Disease | psychotic symptoms | 2.91e-03 | 74 | 113 | 3 | EFO_0005940 | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 2.91e-03 | 21 | 113 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | Parkinson disease | 3.19e-03 | 22 | 113 | 2 | cv:C0030567 | |
| Disease | Malignant tumor of colon | 3.32e-03 | 159 | 113 | 4 | C0007102 | |
| Disease | Autistic Disorder | 3.37e-03 | 261 | 113 | 5 | C0004352 | |
| Disease | mean corpuscular hemoglobin concentration | SWAP70 TNRC6B ZNF217 ACAD10 SKI INTS8 RNF43 MEFV TTBK2 UGT2B10 MACIR | 3.46e-03 | 1105 | 113 | 11 | EFO_0004528 |
| Disease | blood zinc measurement | 3.49e-03 | 23 | 113 | 2 | EFO_0007584 | |
| Disease | Glioblastoma | 3.50e-03 | 79 | 113 | 3 | C0017636 | |
| Disease | Anhedonia | 3.80e-03 | 24 | 113 | 2 | C0178417 | |
| Disease | malaria (is_implicated_in) | 3.80e-03 | 24 | 113 | 2 | DOID:12365 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGAPKSPILVKIRPH | 566 | Q96P26 | |
| DFTPGKPLKCIIKHP | 731 | Q99798 | |
| ARIPPPKCLPSQHKR | 331 | Q96Q91 | |
| PPPLAKAIGLEIKLC | 1581 | P26358 | |
| IKEKAEPPRPLAHLC | 586 | Q96Q27 | |
| CDKLKSFHLSPRGPP | 331 | P78314 | |
| RPIAHLPCPGKATLA | 276 | Q13112 | |
| LRKKPPGTLLPSAHA | 311 | Q6JQN1 | |
| KPLLHQDAKPALRPC | 391 | Q9P1A6 | |
| LPPTDCQHLLKPKTL | 921 | P58397 | |
| LKKLGIPVVCHLPGV | 316 | Q8NE62 | |
| PPVVLRLKCGSGPVH | 96 | P06748 | |
| LKTRAECLLHPLPPS | 366 | Q92617 | |
| HLPPPAKSTLILVCG | 236 | Q6BCY4 | |
| KCLHSVGCPLPLQKP | 191 | P35558 | |
| ESLLEKHLRKPCPDP | 31 | Q75QN2 | |
| KHLRKPCPDPAPVQL | 36 | Q75QN2 | |
| PDCKVLKPLLSGSIP | 576 | Q9NV88 | |
| HRKPSLLAHPGPLVK | 26 | P43631 | |
| KSPSRPILDGKLEPC | 651 | O60890 | |
| LKTRAECLLHPLPPS | 366 | F8W0I5 | |
| SICRKKPDFLPDHPI | 91 | P0DMB2 | |
| HTKLCLEKPLGPSVL | 241 | Q9H790 | |
| TLLRVKCVKHSPPGP | 506 | O75147 | |
| KCVKHSPPGPPILAE | 511 | O75147 | |
| LCLEPPKTRGSHLRP | 426 | Q5HY64 | |
| DAICTHRPDPKIPGL | 13236 | Q8WXI7 | |
| CELKPKPRPANLRHA | 271 | Q9HBL6 | |
| HRKPSLLAHPGPLVK | 26 | P43628 | |
| PRLLAAHCALLPKPG | 81 | P50219 | |
| PIAEKSGICKIRPPA | 36 | Q9BY66 | |
| PDPHKGLVLLPKTEC | 776 | P57737 | |
| HRKPSLLAHPGPLVK | 121 | P43629 | |
| RKLVLLGPHVLCAPP | 401 | Q96B70 | |
| GPLPLCLLKGKRAHS | 151 | Q96GV9 | |
| LSKVHAILSKCPPGP | 791 | O15018 | |
| HRKPSLLAHPGPLVK | 121 | Q8N743 | |
| CHLKPSLLLRPRGKD | 231 | Q9H6R4 | |
| HLDCLDPPLKTIPKG | 511 | Q96BD5 | |
| EGCPKHPKGIISRRD | 1616 | Q5S007 | |
| LKTRAECLLHPLPPS | 366 | A8MRT5 | |
| SLSPQPLPQCKRHLK | 366 | O15553 | |
| GLVKLPHPAAPVTVK | 1216 | Q07864 | |
| PPFLELKGSRHPCIT | 1086 | P52701 | |
| LKTRAECLLHPLPPS | 366 | C9JG80 | |
| PVLKAPVPKRQKCDH | 51 | P58499 | |
| HLGCLDPPLTRMPRK | 751 | O94880 | |
| PPAPKSCLKHRPAAA | 491 | Q6NV74 | |
| RRKPSLLAHPGPLVK | 26 | Q14953 | |
| SPVKCIRPSVLGPLK | 151 | Q7Z309 | |
| QVKRPLPHPKDVKCF | 441 | Q8IV76 | |
| SCLPPVSLLPHEKDK | 186 | Q92794 | |
| KPPVCHGKRLPLTLF | 246 | Q13642 | |
| KLRTSGEGLCPPKPL | 6 | Q0VDD7 | |
| ESCPPKPPRAHELKL | 251 | Q9Y426 | |
| GPRPRPLSELHLKEK | 856 | Q13936 | |
| KPREPLCPLKHPSHQ | 196 | A6NFR6 | |
| LPKAPDKPERHCSLF | 246 | Q8N1I0 | |
| KHPVLNLKDEKPPLC | 201 | Q96ST8 | |
| ESPLCPSLGKHLIPD | 1236 | Q14CM0 | |
| NAKPHALCPERKPLT | 101 | Q6ZUJ4 | |
| EEPPINHPVGCKRKL | 201 | Q9NWK9 | |
| TCRLVKRHKLANPPP | 1021 | Q12955 | |
| THLGICSLEIRKPGP | 311 | A2RUH7 | |
| VPRAKIHSLPPEGKL | 21 | P10176 | |
| PVPPKTGVCHLRLEP | 401 | Q5JRC9 | |
| GKHGPRPCCPLLRKF | 196 | Q8NAJ2 | |
| PPCSEGIHLNIKGRK | 3241 | Q8NDH2 | |
| LKDAKAPPGCLTPER | 256 | Q7Z3D6 | |
| KHKVRCPTPDFEDLP | 421 | Q3B820 | |
| LGTAPHCPRLPLRKT | 1376 | Q9NZM4 | |
| ERLPEHCKLSPGIPL | 526 | P18858 | |
| HCKLSPGIPLKPMLA | 531 | P18858 | |
| HRKPSLLAHPGPLVK | 26 | P43626 | |
| LKTRAECLLHPLPPS | 366 | A6NJU9 | |
| PRLAPSKPFTGCIRH | 1781 | Q16363 | |
| LSKLACVDSPKPLPG | 301 | Q99558 | |
| VAHLPLEKLGPCLPL | 461 | A8MW92 | |
| RVELPCKALGHPEPD | 241 | O60469 | |
| RLCKSFLGEHKPPKL | 161 | P84550 | |
| GKPILCPVHPAEELR | 186 | Q9H8W5 | |
| TLRGHPTPLEREPCK | 1051 | Q07890 | |
| PTVIRIPAKPGKCLH | 256 | Q5HYK7 | |
| PPPDHKGRLSILKVC | 651 | Q9BVQ7 | |
| LHSIKCKPPLSSPIL | 131 | Q9UIC8 | |
| ILSPCKERGPKPEHR | 121 | Q6ZQX7 | |
| GHSKPPHSPLVLKRC | 286 | P01106 | |
| HRKPSLLAHPGPLVK | 121 | Q14943 | |
| KSGLPKPVHSAAPIL | 11 | Q8IVL1 | |
| AHPLICGPPGLDKRL | 696 | Q68DV7 | |
| PFCVLSPVKSPHLRK | 206 | Q9Y6H5 | |
| PSTGPHKLRECLPLI | 31 | P22090 | |
| PSTGPHKLRECLPLI | 31 | Q8TD47 | |
| PVLVRDGKPCHALKA | 206 | O95096 | |
| PSTGPHKLRECLPLI | 31 | P62701 | |
| KVVGRCLPTPKCHTP | 11 | Q02543 | |
| PPPCKKELAASLALG | 196 | P12755 | |
| RPLVHPLTGKALDPA | 1336 | Q9Y566 | |
| KHSPRPEKRETKCPI | 356 | O60284 | |
| GEASIPSPKPKLHAR | 701 | O60284 | |
| IKCLTPHLKDGVPGL | 581 | Q8TCG1 | |
| TLCPRPGLKKLSLHG | 176 | Q8IXR9 | |
| KLPPLCHGLPTQRED | 41 | Q9Y320 | |
| TCRLLVSLGHPVPKP | 41 | Q96NL3 | |
| RPGTNPHKEICPEKL | 136 | Q96NL3 | |
| PTVDLAHKIGRKPPA | 436 | P61129 | |
| LPPKGKLRSLCSQHV | 466 | P51449 | |
| GKESILPALLHKPCV | 481 | Q6IQ55 | |
| VPVKKIPHDLCLFPH | 501 | Q5VUG0 | |
| LPGLLKHSGLPKPCL | 491 | Q12815 | |
| ATPPLIGHLKLEPKR | 921 | Q12888 | |
| APVRCPPAKGASLLH | 121 | I3L0S3 | |
| PTAHPSCLGPKKLSL | 316 | Q86YV5 | |
| SPELRSVCHVPGLKK | 266 | P19474 | |
| HCPLPSLGLKMPIKH | 1226 | Q4KWH8 | |
| KFLKPVELRLPHCDP | 1706 | Q07157 | |
| SPRHLPEPEGGLKCL | 96 | Q13470 | |
| VGGLHCKPAKPLPKE | 276 | P36537 | |
| HPETGKKPVRCIPQL | 276 | O75362 | |
| HLLKLGSPPPHKEAR | 306 | Q9UH65 | |
| LHCAPKSKPVLEPLT | 431 | Q9H7P9 | |
| LGCKKKTCHGPPLIR | 801 | Q9UL62 | |
| SHKLKPLVIGRLPDP | 286 | Q53EQ6 | |
| VKCGSLLSPLLEKPP | 1071 | Q9H9Y6 | |
| SLDDKIPHKSPCPRR | 346 | Q96S53 | |
| KVPKPRPGCCAKHGL | 361 | Q8NFY4 | |
| KELACSPHPPKLLQP | 371 | O15016 | |
| HKVLLKRGQPPPPSC | 101 | Q9UPQ9 | |
| LSPPSIHCLGPIKLE | 746 | Q96JC1 | |
| CPVKLRHVDPKRPHR | 386 | Q86SH2 | |
| PIAEKSGICKIRPPA | 36 | P41229 |